Advertisement

More articles from Preclinical Development

  • BiKEs and TriKEs Enhance NK Cell Effector Function
    Michelle K. Gleason, Michael R. Verneris, Deborah A. Todhunter, Bin Zhang, Valarie McCullar, Sophia X. Zhou, Angela Panoskaltsis-Mortari, Louis M. Weiner, Daniel A. Vallera, Jeffrey S. Miller
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2674-2684; DOI: 10.1158/1535-7163.MCT-12-0692
  • Ganetespib Activity in KRAS-Mutant NSCLCs
    Jaime Acquaviva, Donald L. Smith, Jim Sang, Julie C. Friedland, Suqin He, Manuel Sequeira, Chaohua Zhang, Yumiko Wada, David A. Proia
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2633-2643; DOI: 10.1158/1535-7163.MCT-12-0615
  • Aurora Kinase Targeting Triple-Negative Breast Cancer
    Angela Romanelli, Anderson Clark, Franck Assayag, Sophie Chateau-Joubert, Marie-France Poupon, Jean-Luc Servely, Jean-Jacques Fontaine, Xiaohong Liu, Edward Spooner, Samantha Goodstal, Patricia de Cremoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2693-2703; DOI: 10.1158/1535-7163.MCT-12-0441-T
  • DNA Methylation Score and Sensitivity of Multiple Myeloma Cells to DNMTi
    Jérôme Moreaux, Thierry Rème, Wim Leonard, Jean-Luc Veyrune, Guilhem Requirand, Hartmut Goldschmidt, Dirk Hose, Bernard Klein
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2685-2692; DOI: 10.1158/1535-7163.MCT-12-0721
  • Targeting IAPs in Medulloblastoma
    Joanna Keating, Maria Tsoli, Andrew R. Hallahan, Wendy J. Ingram, Michelle Haber, David S. Ziegler
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2654-2663; DOI: 10.1158/1535-7163.MCT-12-0352
  • BMS-754807 Enhances Gemcitabine Response in PDAC
    Niranjan Awasthi, Changhua Zhang, Winston Ruan, Margaret A. Schwarz, Roderich E. Schwarz
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2644-2653; DOI: 10.1158/1535-7163.MCT-12-0447
  • PSMA-Specific BiTE Antibody
    Matthias Friedrich, Tobias Raum, Ralf Lutterbuese, Markus Voelkel, Petra Deegen, Doris Rau, Roman Kischel, Patrick Hoffmann, Christian Brandl, Joachim Schuhmacher, Peter Mueller, Ricarda Finnern, Melanie Fuergut, Dieter Zopf, Jerry W. Slootstra, Patrick A. Baeuerle, Benno Rattel, Peter Kufer
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2664-2673; DOI: 10.1158/1535-7163.MCT-12-0042
  • Anti-CCR4 Antibody for Immunotherapy
    De-Kuan Chang, Jianhua Sui, Shusheng Geng, Asli Muvaffak, Mei Bai, Robert C. Fuhlbrigge, Agnes Lo, Anuradha Yammanuru, Luke Hubbard, Jared Sheehan, James J. Campbell, Quan Zhu, Thomas S. Kupper, Wayne A. Marasco
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2451-2461; DOI: 10.1158/1535-7163.MCT-12-0278
  • Targeting of IFNγ to Tumor Fibroblasts and Pericytes
    Ruchi Bansal, Tushar Tomar, Arne Östman, Klaas Poelstra, Jai Prakash
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2419-2428; DOI: 10.1158/1535-7163.MCT-11-0758
  • Overcoming Cisplatin Resistance Using Copper Chelators
    Zheng D. Liang, Yan Long, Wen-Bin Tsai, Siqing Fu, Razelle Kurzrock, Mihai Gagea-Iurascu, Fan Zhang, Helen H.W. Chen, Bryan T. Hennessy, Gordon B. Mills, Niramol Savaraj, Macus Tien Kuo
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2483-2494; DOI: 10.1158/1535-7163.MCT-12-0580

Pages